Abstract

BackgroundDrug-disease associations provide important information for the drug discovery. Wet experiments that identify drug-disease associations are time-consuming and expensive. However, many drug-disease associations are still unobserved or unknown. The development of computational methods for predicting unobserved drug-disease associations is an important and urgent task.ResultsIn this paper, we proposed a similarity constrained matrix factorization method for the drug-disease association prediction (SCMFDD), which makes use of known drug-disease associations, drug features and disease semantic information. SCMFDD projects the drug-disease association relationship into two low-rank spaces, which uncover latent features for drugs and diseases, and then introduces drug feature-based similarities and disease semantic similarity as constraints for drugs and diseases in low-rank spaces. Different from the classic matrix factorization technique, SCMFDD takes the biological context of the problem into account. In computational experiments, the proposed method can produce high-accuracy performances on benchmark datasets, and outperform existing state-of-the-art prediction methods when evaluated by five-fold cross validation and independent testing.ConclusionWe developed a user-friendly web server by using known associations collected from the CTD database, available at http://www.bioinfotech.cn/SCMFDD/. The case studies show that the server can find out novel associations, which are not included in the CTD database.

Highlights

  • Drug-disease associations provide important information for the drug discovery

  • We proposed a similarity constrained matrix factorization method for the drug-disease association prediction (SCMFDD), which makes use of known drug-disease associations, drug features and disease semantic information

  • Computational experiments show that SCMFDD can produce high-accuracy performances on benchmark datasets and outperform existing state-of-the-art prediction methods, i.e. PREDICT, TL-HGBI and LRSSL when evaluated by five-fold cross validation and independent testing on the same datasets

Read more

Summary

Introduction

Drug-disease associations provide important information for the drug discovery. The development of computational methods for predicting unobserved drug-disease associations is an important and urgent task. A great number of computational methods have been proposed to predict drug-disease associations. One type of methods makes use of biological elements shared by drugs and diseases to predict drug-disease associations. Eichborn J et al [5] studied drug-disease relations based on drug side effects. Yu et al [8] used common protein complexes related to drugs and diseases. These methods have to use elements shared by drugs and diseases, but many drugs and diseases do not

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.